Wednesday, March 27, 2013 4:05:04 PM
http://www.nasdaq.com/symbol/appa/after-hours#.UVNQ0VeaHWJ
Recent HRTX News
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2024 01:06:35 PM
- Heron Therapeutics Announces Third Quarter 2024 Financial Results and Narrows Financial Guidance • PR Newswire (US) • 11/12/2024 12:55:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/06/2024 07:08:57 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 11/05/2024 05:41:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/04/2024 10:09:40 PM
- Heron Therapeutics Announces Appointment of Michael Kaseta to Board of Directors • PR Newswire (US) • 11/04/2024 10:00:00 PM
- Heron Therapeutics to Report Third Quarter 2024 Financial Results On Tuesday, November 12, 2024 • PR Newswire (US) • 10/29/2024 08:05:00 PM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 10/24/2024 06:02:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/21/2024 07:55:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/21/2024 07:53:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/21/2024 07:49:55 PM
- Heron Therapeutics Reaffirms Availability and Ample Supply of CINVANTI®, SUSTOL®, and APONVIE® as Alternatives During the Potential Shortage of Intravenous Fluids • PR Newswire (US) • 10/10/2024 08:08:00 PM
- Heron Therapeutics Announces FDA Approval of the Prior Approval Supplement Application for ZYNRELEF® Vial Access Needle ("VAN") • PR Newswire (US) • 09/25/2024 12:00:00 PM
- Heron Therapeutics Announces Appointment of Brett Fleshman as Chief Business Officer • PR Newswire (US) • 09/03/2024 12:00:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/06/2024 08:35:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 08:05:13 PM
- Heron Therapeutics Announces Second Quarter 2024 Financial Results and Narrows Financial Guidance • PR Newswire (US) • 08/06/2024 08:05:00 PM
- Heron Therapeutics to Report Second Quarter 2024 Financial Results On Tuesday, August 6, 2024 • PR Newswire (US) • 07/30/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/22/2024 01:54:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/22/2024 01:44:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/22/2024 01:32:57 PM
- Heron Therapeutics Announces the Inclusion of ZYNRELEF® as a Qualifying Product Under the Proposed 2025 Non-Opioid Policy for Pain Relief Under the OPPS and the ASC Payment System • PR Newswire (US) • 07/15/2024 12:00:00 PM
- Heron Therapeutics Announces Acceptance of the Prior Approval Supplement Application for ZYNRELEF® Vial Access Needle ("VAN") • PR Newswire (US) • 07/02/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/18/2024 08:43:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 06:21:42 PM
FEATURED Are we about to see a comeback? Steakholder Foods Charges Forward with New Commitments from Multiple International Players as it Transitions to Revenue Generation • Nov 18, 2024 11:56 AM
FEATURED North Bay Resources Announces Production of Gold Concentrate and Refinery Shipment at Bishop Gold Mill, California • Nov 18, 2024 9:00 AM
One World Products Sets New Standards in Sustainability With Strategic Hemp Innovations • OWPC • Nov 18, 2024 7:54 AM
Kona Gold Beverage, Inc. Updates Multi-Million Dollar Merger and Posts Over $1.2 Million in Q3 Revenues • KGKG • Nov 15, 2024 10:36 AM
HealthLynked Corp. Announces Third Quarter and Year-to-Date 2024 Results with Strategic Restructuring, Third-Party Debt Repayment, and Core Technology Focus • HLYK • Nov 15, 2024 8:00 AM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM